SAN DIEGO, April 30, 2024 /PRNewswire/ Neurocrine Biosciences, Inc. today announced the U.S. Food and Drug Administration has approved INGREZZA® SPRINKLE capsules, a new oral granules.
Neurocrine Biosciences Announces U S FDA Approval of INGREZZA® SPRINKLE (valbenazine) Capsules lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Neurocrine Biosciences Announces U S FDA Approval of INGREZZA® SPRINKLE (valbenazine) Capsules prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.